子痫前期综合征胎盘介导相关因素预警、早期发现及临床处理选项

doi:10.7504/fk2016030104

摘要/Abstract

摘要：

早发子痫前期与晚发子痫前期在发病机制和临床表现存在明显不同。子痫前期与其他胎盘介导妊娠并发症包括妊娠丢失、小于胎龄儿和胎盘早剥及早产有着密切关联。胎盘成为子痫前期尤其早发子痫前期的关注焦点。该文仅就作者多年研究认知和经验，剖析和浅谈如何发现胎盘介导的相关因素、如何早期预警及相应的临床处理选项。

关键词: 子痫前期, 胎盘介导, 预警, 临床处理

Abstract:

Abstract:Early onset preeclampsia and late onset preeclampsia are significantly different in the pathogenesis and clinical manifestation. There is an association between preeclampsia and other placenta-mediated pregnancy complications, including the pregnancy loss, small-for-gestational-age, and placental abruption and premature birth. The placenta has become a focus in preeclampsia especially on early onset ones. In this article, we talk about our experience of how to find the placental related factors and the early warning, and the management options.

Key words: preeclampsia, placenta-mediated, warning, clinical management

中图分类号:

R714.24+

杨孜. 子痫前期综合征胎盘介导相关因素预警、早期发现及临床处理选项[J]. 中国实用妇科与产科杂志, DOI: 10.7504/fk2016030104.

YANG Zi.. Early warning and detection and management of placenta-mediated factors in preeclampsia syndrome.[J]. Acta Metallurgica Sinica, DOI: 10.7504/fk2016030104.

参考文献

[1]     杨孜，叶蓉华．重度妊娠高血压综合征发生时间与母儿预后的关系[J]．北京医科大学学报，1996，28(4):298-300．

[2]     杨孜. 早发型重度先兆子痫-产科医师面临的挑战[J].中国妇产科临床杂志，2003，4（2）：83-84.

[3]     杨孜. 生物学标记结合临床风险推动子痫前期预测更上一层楼[J]. 中华围产医学杂志,2011,14(7):385-389.

[4]     杨孜，李蓉，石凌懿，等. 早发型重度先兆子痫的临床界定及保守治疗探讨[J]. 中华妇产科杂志，2005,40（5）：302-305.

[5]     Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia[J]. N Engl J Med，2004，350(7):672-683.

[6]     Chaiworapongsa T, Romero R, Kim YM, et al. Plasma soluble vascular endothelial　growth factor receptor-1 concentration is elevated prior to the clinical　diagnosis of pre-eclampsia[J]. J Matern Fetal Neonatal Med，2005，17(1):3-18.

[7]    Verlohren S, Galindo A, Schlembach D, et al. An automated method for the determination of the sFlt-1/PlGF ratio in the assessment of preeclampsia[J]. Am J Obstet Gynecol，2010,202(2):161.e1-161.e11.

[8]     Verlohren S, Herraiz I, Lapaire O, et al. New gestational phase–specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia[J]. Hypertension，2014,63(2): 346-352.

[9]     Smith GC， Crossley JA， Aitken DA，et al. Circulating angiogenic factors in early　pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth[J]. Obstet Gynecol,2007,109:1316-1324.

[10]     Sunderji S, Gaziano E,Wothe D, et al. Automated assays for sVEGF R1 and PlGF　as an aid in the diagnosis of preterm preeclampsia: a prospective clinical　study[J]. Am J Obstet Gynecol,2010,202(1):40-47.

[11]     Qazi U, Lam C, Karumanchi SA,et al.Soluble Fms-like tyrosine kinase associated with preeclampsia in pregnancy in systemic lupus erythematosus[J].J Rheumatol,2008,35:631-634.

[12]     杨孜. 子痫前期多因素发病及多机制发病通路之综合征再认识[J]. 中华医学杂志, 2015, 95(1):7-9.

[13]     Redman CW, Sargent IL. Immunology of pre-eclampsia[J]. Am J Reprod Immunol,2010,63(6):534-543.

[14]     Quinn KH, Lacoursiere DY, Cui L, et al. The unique pathophysiology of early-onset severe preeclampsia: role of decidual T regulatory cells[J]. J Reprod Immunol,2011,91(1-2):76-82.

[15]     Cotechini T, Graham CH. Aberrant maternal inflammation as a cause of pregnancy complications: a potential therapeutic target? [J]. Placenta,2015,36(8):960-966.

[16]     杨孜，张为远. 剖析子痫前期发病的多因素拓宽临床实践研究的多视角[J].中华妇产科杂志,2015,50（10）:734-738.

[17]     李维,杨孜,王海玲,韩怡炜. 子痫前期复发影响因素临床研究[J]. 中国实用妇科与产科杂志,2014,30（10）:780-785.

[18]     沈洁，杨孜，王伽略. 母体基础疾病状况对子痫前期发病的影响[J]. 中华妇产科杂志，2012, 47(6)：405-411.

[19]     王伽略，杨孜，宋颖,等. 非规律产前检查孕妇子痫前期发病的影响因素[J].中华围产医学杂志,2015,18(6):425-429.

[20]     宋颖, 杨孜, 沈洁,等. 规律产前检查轻重度子痫前期患者早期临床发病特点分析[J]. 中国实用妇科与产科杂志, 2014, 30(6): 457-461.

[21]     Milne F,Redman C,Walker J, et al. The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community[J]. BMJ,2005,330(12) :576-580.

[22]     ACOG.Committee opinion No. 638: first-trimester risk assessment for early-onset preeclampsia[J]. Obstet Gynecol,2015,126 (3):e25-27.

[23]     North RA, McCowan LME, Dekker GA, et al. Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohort[J]. BMJ,2011,342:d1875.

[24]     郭宏霞,杨孜. 妊娠合并自身免疫性疾病临床监察与处理[J]. 中国实用妇科与产科杂志,2014,30（6）:403-406.

[25]     郭艳军，杨孜，王伽略,等.早产临床风险因素的探讨[J]. 中国实用妇科与产科杂志,2007,23(10):773-775.

[26]     史峻梅，杨孜，陈蕾，等. 重度子痫前期患者临床发病前预警信息分析[J]. 中华妇产科杂志, 2009,44(5):337-340.

[27]     杨孜. 早发型子痫前期临床与基础研究并进相得益彰[J]. 中国妇产科临床杂志,2010,11(4):241-243.

[28]     史峻梅, 杨孜. 陈蕾,等.重度子痫前期临床警示因素与产前随访时限[J]. 中国妇幼保健，2009，24:2768-2771.

[29]     杨孜. 子痫前期预测预防是固步自封,还是探索求进强化预警[J]. 中国实用妇科与产科杂志,2014,30(1):3-7.

[30]     杨孜. 羊水过少的病因及处理[J]. 实用妇产科杂志,2008,24(4):197-199.

[31]    American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy[J]. Obstet Gynecol, 2013, 122(5):1122-1131.

（2015-12-10收稿）